Diabetes Tracker helps users take control of type 1 and 2 diabetes as well as prediabetes and gestational diabetes. Document exercise and food intake so you can monitor your weight, and view stats and food grades for different foods. It also allows you to keep tabs on water intake, weight, HbA1c, cholesterol, net carbs, and other health factors. Virtual coaching can assist you in managing your health in addition to the analytical tools. This app delivers diabetes management that is truly at your fingertips.
Diabetes Depot carries a full line insulin pump supplies, including all major insulin infusions sets, insulin reservoirs and cartridges available in Canada, all at significant discounts below the manufacturer's list price. Our product line of diabetic supplies, required daily by people living with diabetes, include blood glucose meters, glucose test strips, lancets, insulin pen needles, insulin products, Dex-4 glucose tablets and Emla anesthetic cream. We also carry accessories such as pump clips, pump cases & pouches, prep pads, battery caps, diabetic socks, and helpful books on diabetes… everything an insulin pump user would require. Plus, because the Diabetes Depot is located within Stutt's Pharmacy, we also offer a complete prescription service.
24. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009 Apr;42(2):377–81. doi: 10.1016/j.jbi.2008.08.010. http://linkinghub.elsevier.com/retrieve/pii/S1532-0464(08)00122-6. [PMC free article] [PubMed] [CrossRef]
Since we do not practice band-aid medicine, insurance companies do not pay for all of our services. It’s not that we refuse to accept insurance, it’s that insurance companies refuse to accept us. Insurance companies restrict what we can do, so that limits your ability to truly achieve health and wellness. But because we are working for you (not the insurance company), there are no restrictions in what can be achieved. You will actually get so much more for your time and money by working with Cheryl (an integrative practitioner), since our time is no longer wasted following insurance company rules and hiring additional support staff to file insurance claims.
Strengths of the intervention were that it was theoretically based, the information reinforced messages from standard care, and it was system initiated, personally tailored, and used simple technology. These strengths result in high relevance to diverse individuals, increasing the intervention’s reach and acceptability. Unlike SMS4BG, previous diabetes SMS programmes have largely focused on specific groups—for example, limiting their generalisability. Furthermore, the SMS4BG intervention was tailored and personalised to the individual. Although this specificity results in a more complex intervention in relation to its delivery, it appears to be a worthwhile endeavour with high satisfaction and the majority of participants happy with their message dosage.
Nearly half of American adults have diabetes or prediabetes; more than 30 million adults and children have diabetes; and every 21 seconds, another individual is diagnosed with diabetes in the U.S. Founded in 1940, the American Diabetes Association (ADA) is the nation’s leading voluntary health organization whose mission is to prevent and cure diabetes, and to improve the lives of all people affected by diabetes. The ADA drives discovery by funding research to treat, manage and prevent all types of diabetes, as well as to search for cures; raises voice to the urgency of the diabetes epidemic; and works to safeguard policies and programs that protect people with diabetes. In addition, the ADA supports people living with diabetes, those at risk of developing diabetes, and the health care professionals who serve them through information and programs that can improve health outcomes and quality of life. For more information, please call the ADA at 1-800-DIABETES (1-800-342-2383) or visit diabetes.org. Information from both of these sources is available in English and Spanish. Find us on Facebook (American Diabetes Association), Twitter (@AmDiabetesAssn) and Instagram (@AmDiabetesAssn)
Mobile phone ownership rates are increasing. Similar to trends seen in the United States and Canada, where mobile phone ownership is 72% and 67%, respectively , 70% of New Zealanders own a mobile phone, making diabetes apps potentially available to most people . Limited research exists into the use of diabetes apps in New Zealand. However with increasing rates of both diabetes prevalence and mobile phone ownership, access to safe apps is essential for both HPs as potential app prescribers and patients as app users [21,22]. In Scotland, a survey of people with diabetes found high mobile phone ownership (67%) with over half reporting an interest in using apps for self-management of diabetes, but app usage in only 7% of responders . The objectives of this study were (1) To establish whether people with diabetes use apps to assist with diabetes self-management and which features are useful or desirable, and (2) To establish whether HPs treating people with diabetes recommend diabetes apps, which features were thought to be useful, and which features were they confident to recommend.
The results of study after the application of the educational program were significant on regular self-checks of blood sugar levels, the frequency of hypoglycemia or hyperglycemia, the frequency of daily examination of the feet and examination of the eyes, and engagement in exercising. There was a positive improvement in such behaviors at 3 months after the educational intervention. However, this improvement lessened at 6 months. In addition, there was a reduction in the frequency of weekly exercise. It is interesting to note that half of the patients at the end of 6 months indicated that they did not allocate any time for exercise. One possible explanation for this might be cultural, in that it discourages people, especially women (half of the patients in this study were women) from frequent exercise. Another reason is the high cost of membership of sports facilities and limited safe public places for exercise.
Samples were collected from both deep and shallow sites of subjects with periodontitis. Prior to sample collection, selected sites were isolated and supragingival plaque was removed. Subgingival plaque was collected and pooled from four non-adjacent proximal sites with probe depths of 6 mm, BOP, and GI >1 (disease or deep-site samples) by inserting 15 sterile endodontic paper-points (Caulk-Dentsply, Milford, DE, USA). Samples were similarly acquired from four sites with probe depths of 3, no BOP and GI 1 and separately pooled (healthy or shallow-site samples). A total of 15 randomly selected interproximal sites were sampled from periodontally healthy subjects. Samples were placed in 1.5-ml microcentrifuge tubes and frozen at −20 °C until further analysis.
Only children aged <15 yr were included. Type 1 diabetes was diagnosed based on clinical features. All patients had elevated blood glucose at presentation: either a random measurement of ≥11.1 mmol/l and presence of classical symptoms, or fasting blood glucose ≥7.1 mmol/l. In addition, all patients met at least one of the following criteria: a) diabetic ketoacidosis; b) presence of at least two type 1 diabetes antibodies (to glutamic acid decarboxylase, islet antigen 2, islet cell, or insulin autoantibodies); or c) ongoing requirement for insulin therapy. Clinical and demographic data were prospectively recorded on all patients at each outpatient visit.
Patients were involved in all stages of the study, including the initial conceptualisation and formative work leading to the development of SMS4BG (for more information, see the development paper28). Patient feedback informed the intervention modality, purpose, and structure, and patients reviewed intervention content before it was finalised. Patient feedback on the acceptability of SMS4BG through the pilot study28 led to improvements to the intervention including additional modules, the option for feedback graphs to be posted, additional tailoring variables, and a longer duration of intervention. Patient feedback also informed the design of this trial—specifically its duration, the inclusion criteria, and recruitment methods. Additionally, patients contributed to workshops of key stakeholders held to discuss interpretation, dissemination of the findings, and potential implementation. We have thanked all participants for their involvement and they will be given access to all published results when these are made publicly available.
Moreover, the frequency of patients having breakfast, lunch, and dinner was reduced. One possible explanation for this reduction might be some factors other than the educational intervention per se despite that, almost half (50%) the patients at the end of 6-months of enrollment in the educational program continued to examine their feet and eyes constantly. This result is in line with the results of a study by Cerkoney and Hart, who indicated that a correlation between the consistency levels of diabetics with respect to particular parts of therapeutic regimen (dietary regimen, hypoglycemia management, and foot care). Schwedes et al. reported that self-monitoring was possible for the majority of patients with a good adherence to the monitoring schedule. They found that 87% of the study group continuously observed their blood glucose levels at the end of the follow-up period. Moreover, Wynn Nyunt et al. reported that a significant difference between the two groups was observed in favor of the CM group although both study groups significantly improved A1C. A1C was reduced by 0.60 ± 1.1 U in the intervention group and by 0.50 ± 1.7 U in the control group. It is worth mentioning that the intervention group of their study had lower A1C levels before the intervention. However, they concluded that this observation cannot be attributed to the educational program because of the limited size of the study.
Subjects with generalized moderate to severe chronic periodontitis (attachment loss 5 mm, probing pocket depths 5 mm, mean gingival index (Loe and Silness, 1963) >1 in 30% of more of sites (Armitage, 1999)) were recruited from two centers in India and the United States, and informed consent obtained. A total of 25 subjects were recruited into each of the following groups: normoglycemic nonsmokers, hyperglycemic nonsmokers, normoglycemic smokers and hyperglycemic smokers. Additionally, 75 periodontally healthy individuals were recruited and distributed equally among the three groups: normoglycemic nonsmoker, hyperglycemic nonsmoker and normoglycemic smoker. Periodontal health was defined as attachment loss 1 mm, probing pocket depths 3 mm, mean gingival index <1. Smokers were defined as10 pack-year histories and currently smoking more than 3 times a week, nonsmokers were defined as those who smoked <100 cigarettes in their lifetime and were not currently smoking (CDC guidelines). Type 2 diabetes was defined as untreated adult-onset hyperglycemia with a glycated hemoglobin (HbA1c) level of 6.5 and normoglycemia as HbA1c of 6 (American Diabetes Association, 2015). Exclusion criteria included conditions that required the use of prophylactic antibiotics, current or planned pregnancy, HIV infection, long-term (>3 months) use of medications known to cause gingival changes, (for example, immunosuppressants, phenytoin, calcium channel blockers, aspirin, NSAIDS, bisphosphonates or steroids), antibiotic therapy or oral prophylactic procedures within the last 3 months and less than 20 teeth in the dentition. The groups were frequency matched for age, gender, BMI and extent and severity of periodontal destruction.
Phoenix Health Centre carries out pre employment medical assessments for several large employers in Whakatane. These give a base line recording of an employee’s health status at the time they were employed. It is then possible to monitor the employee’s health in relation to the hazards they may be exposed to in the workplace. If required we also undertake monitored urine sampling for ESR drug testing.